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The glycoprotein envelope of alphaviruses consists of two proteins, E1 and E2. E1 is responsible for fusion and E2 is responsible for receptor
binding. An atomic structure is available for E1, but one for E2 has not been reported. In this study, transposon linker-insertion mutagenesis was
used to probe the function of different domains of E2. A library of mutants, containing 19 amino acid insertions in the E2 glycoprotein sequence of
the prototype alphavirus, Sindbis virus (SINV), was generated. Fifty-seven independent E2 insertions were characterized, of which more than half
(67%) gave rise to viable virus. The wild-type-like mutants identify regions that accommodate insertions without perturbing virus production and
can be used to insert targeting moieties to direct SINV to specific receptors. The defective and lethal mutants give insight into regions of E2
important for protein stability, transport to the cell membrane, E1–E2 contacts, and receptor binding.
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Alphaviruses are enveloped positive-strand RNA viruses
belonging to the family Togaviridae. They are arthropod-borne
viruses that cause a range of diseases from the relatively mild
fever, rash and arthritis caused by the prototype virus Sindbis
(SINV) to the more severe encephalitis caused by the human
and veterinary pathogens, Eastern, Western and Venezuelan
equine encephalitis viruses. The alphaviruses have been found
in all continents throughout the world (La Linn et al., 2001;
Strauss and Strauss, 1994).
The mature virion is composed of three major structural
proteins, the capsid protein and two integral membrane
glycoproteins E1 and E2. A small 6K protein is found in sub-
stoichiometric amounts in the particle (Gaedigk-Nitschko and
Schlesinger, 1990; Lusa et al., 1991). The 11,703 nucleotide (nt)
viral genome of SINV is encapsidated by 240 copies of the
capsid protein in the cytoplasm of infected cells. The E1 and E2
glycoproteins are translated from a subgenomic RNA and co-⁎ Corresponding author. Fax: +1 765 496 1189.
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they are glycosylated and then transported through the Golgi
apparatus to the plasma membrane (Melancon and Garoff,
1987; Wirth et al., 1977). The nucleocapsid core then acquires
a lipid envelope, embedded with E1 and E2 glycoproteins, and
buds out of the cell. In the mature virion, the glycoproteins are
arranged into 80 spike-like structures, each spike being
composed of a trimer of E2/E1 heterodimers (von Bonsdorff
and Harrison, 1975, 1978; Cheng et al., 1995; Mancini et al.,
2000; Mukhopadhyay et al., 2006; Paredes et al., 1993; Pletnev
et al., 2001; Zhang et al., 2002).
E2 is a 423-amino acid (∼50 kDa) Type I transmembrane
protein. It consists of an N-terminal (1–364, SINV numbering)
hydrophilic region, followed by a 26-residue membrane-
spanning region (365–390) and a 33-residue (391–423)
cytoplasmic endo domain. SINV E2 is glycosylated with two
asparagine (N)-linked carbohydrate chains at N-196 and N-318
(Mayne et al., 1985). In addition, certain cysteine residues in the
cytoplasmic domain and membrane-spanning region of E2 have
been implicated as sites for palmitoylation (Schmidt et al.,
1979). During the course of the SINV life cycle the E2
glycoprotein is responsible for cell receptor binding while E1 is
Table 1
Amino acid sequences of the three possible open reading frames of the
transposon insertion sequence
ORF a Amino acid sequence b
1 L S L V H I L R P Q D V Y K R Q
2 C L L Y T S C G R K M C T R D
3 V S C T H L A A A R C V Q E T
a ORF: open reading frame.
b Depending on the ORF there are 16 (ORF1) or 15 (ORF2 and 3) invariant
amino acids. The remaining 3 or 4 amino acids are the result of duplication of
host target sequences.
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membrane.
Although alphaviruses have long served as a model system
for the study of virus structure and assembly, an atomic
resolution structure for E2 is still lacking. In the absence of
structural data for E2, a random transposon linker-insertion
mutagenesis system was used to probe the functions of the
different domains of the glycoprotein. A 19 amino acid insertion
was introduced into E2 using a Tn5 transposon-based linker
insertion mutagenesis system resulting in the generation of a
library consisting of 57 independent E2 insertion mutations.
The location of each of the insertions was determined by
sequencing the E2 region of the cDNA and virus was generated
by RNA transcription and transfection. The insertion mutants
were characterized as to their level of E2 expression, E2
transport to the plasma membrane and the affect of the insertion
on virus viability. The effects of the insertions on virus–receptor
interactions were probed by virus neutralization assays. The
results indicate that a majority of the insertions gave rise to
viable virus. Some insertions had no impact on virus growth as
determined by plaque assays and one-step growth assays. These
sites may be used for inserting targeting ligands in order to
target SINV to specific cell receptors in certain gene therapy
applications. The results of this mutational analysis describe
domains of E2 critical for the structural integrity of the protein,
critical for transport to the plasma membrane, and critical for
virus–host interactions.
Results
Generation of an E2 insertion library
To probe the structure of E2 and identify the regions of the
protein integral to its function, a random insertion library was
generated by transposon linker-insertion mutagenesis. In order
to rapidly generate a large number of independent insertions in
E2, the Tn5 transposase-based EZ∷TN In Frame Linker
Insertion Kit (Epicentre, Madison, WI) was used. Tn5 trans-
poson insertions into target DNA are random, and the trans-
posase will transpose any DNA sequence contained between its
19-bp Mosaic End (ME) Tn5 transposase recognition sequences
(Goryshin and Reznikoff, 1998). The EZ∷TN <NotI/KAN-3>
transposon is an 1167-bp fragment of DNA which contains a
kanamycin resistance (KanR) marker between the Tn5 transpo-
sase ME sequences. Removal of the KanR gene from the
transposon by NotI digestion leaves behind a 57-nt insertion
which is open in all three reading frames ensuring that all
insertions will be productive (Table 1).
To maximize the number of transposition events occurring in
the E2 target sequence, a fragment of pToto64 (SINV cDNA)
(Owen and Kuhn, 1996) that encoded the first 407 amino acids
of E2 (ectodomain and transmembrane domain) was subcloned
into pJRtac99 (American Type Culture Collection) to generate
pJRtac99-E2. This vector was subsequently used in an in vitro
transposon reaction that resulted in the random insertion of the
transposon into pJRtac99-E2 to generate pJRtac99-E2TnKan
(Fig. 1). Plasmids containing the transposon were selected byplating on media containing both kanamycin and chloramphe-
nicol. Approximately 1400 colonies were recovered in this
manner. The frequency of transposition into the plasmid was
calculated to be about 14%, which is within the expected range
(0.5–20%). In order to identify plasmids with insertions
specifically in the SINV cDNA fragment, pJRtac99-E2TnKan
was purified from individual KanR/CamR colonies (∼200
colonies), restriction digested to release the SINV cDNA, and
the fragments were analyzed on an agarose gel. SINV cDNA
fragments with inserts were ∼1100 bp larger, and 104 plasmids
out of 200 (52%) had a transposon insertion in the cDNA
sequence. These SINV cDNA fragments were gel-purified for
ligation back into pToto64, to generate pToto64–TnKan. NotI
digestion of pToto64–TnKan eliminated the KanR gene and
regenerated the SINV cDNA, pToto64–Tn, which now
contained a 57 nt insertion in E2 (Fig. 1). In order to determine
the location of the insertions, Toto64-Tn plasmids were
sequenced with primers flanking the E2 coding sequence. 104
independent clones were sequenced and 57 (55%) had
transposon insertions in E2.
Distribution of transposon insertions in E2
Transposon insertions were found throughout the E2
sequence (Figs. 2A and B). However, certain sites were
represented more than once among the 57 independent clones
characterized, and as a result, only 42 of the 57 (74%) transposon
insertion sites were unique. Sites with multiple transposition
events may represent hotspots for Tn5 transposase-based
mutagenesis (Fig. 2C). In contrast, several regions of the E2
sequence (amino acids 36–85, 120–152 and 170–220) did not
have any insertions (Fig. 2C). Amino acid residues 170–220 are
especially interesting as it has been shown to contain numerous
SINV neutralizing epitopes (reviewed in Strauss and Strauss,
1994). However, none of the transposon insertions were located
within this region. The closest insertion was lethal for the virus
and occurred at amino acid 221. Since insertions within residues
170–220 may interfere with virus–receptor interactions and
provide insight into the specific residues involved in receptor
binding, we decided to screen specifically for insertions in this
region. A high-throughput approach was employed where
CamR/KanR bacterial colonies were picked using an automated
colony picker into 96-well plates containing Luria–Bertani (LB)
broth, and the resulting cultures were used for colony PCR in
order to amplify the 170–220 region. Transposon insertions
Fig. 1. Generation of an E2 transposon insertion library. A schematic outlining
the strategy employed to generate the library of E2 transposon mutants.
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(1100 bp larger). Three 96-well plates were screened in this
manner (288 colonies), but we were unable to identify any
insertions in this region. Together with the initial colonies
screened to generate the E2 transposon insertion library, over
400 colonies have been screened and none of them contained
insertions in the 170–220 region. This region may have
nucleotide sequences or secondary structures that inhibit Tn5
transposase-based insertions.
Majority of the insertions in E2 do not abolish protein
expression
To assess the affect of the insertions on E2 protein
expression, BHK-15 cells were transfected with Toto64-Tn
RNA, and cytoplasmic extracts were analyzed by Western blot.
Cells were harvested 12 h post-transfection and probed with
anti-E2 (cytoplasmic domain) and anti-capsid protein anti-
bodies. Table 2 lists all the transposon insertion mutants along
with the relative level of E2 and capsid protein expression for
each mutant. The expression of the capsid protein served as an
internal control to demonstrate the replication and translational
efficiency of the cDNA clone. All the cDNA clones tested
expressed levels of CP similar to wild-type SINV (Table 2).
IFAs were also done on BHK cells electroporated with the
mutant constructs which further confirmed the Western blot
results (data not shown).
Of the 57 independent cDNA clones tested, only 3 did not
produce any detectable E2 as determined by Western blot
analysis (Table 2). These results indicate that a majority of the
insertions did not abolish E2 protein expression, although some
did show reduced levels of the protein. The insertions that did
abolish E2 expression were located at E2-35, E2-103 and E2-
324. Transposon insertions in the vicinity of residue 35 also
resulted in dramatically reduced E2 expression. Insertions at
amino acid positions 33 and 53 were lethal and E2 expression
was less than 25% of wild-type (Table 2). Therefore, the region
between amino acids 33 and 53 appears to be important for
proper protein folding.
Although no E2 expression was detected for E2-103 and E2-
324, other insertions adjacent to these residues had levels of E2
expression 75%–100% of wild-type (Table 2). Therefore, the
lack of protein expression in these mutants may be a function of
the particular ORF expressed.
Majority of insertions in E2 result in viable virus
The effect of the insertions on the virus life cycle was
determined by the ability of the mutants to form plaques on
BHK monolayers. In vitro transcribed RNAs from the E2
transposon insertion mutations were transfected into BHK cells,
and the resulting viruses were isolated and characterized by
plaque assay. The plaque sizes were compared to that of wild-
type SINV at 48 h post-infection. Wild-type SINV forms
plaques that are 3.5–4 mm in diameter 48 h post-infection, and
this was classified as a large-plaque phenotype (LP). A virus
with a medium-plaque phenotype (MP) forms plaques 2.5–
Fig. 2. Distribution of transposon insertions in E2. (A) A schematic of the SINV E2 protein. The hatched area represents the transmembrane (TM) region. The
glycosylation sites at 196 and 318 are represented by a stick and ball. CT: cytoplasmic tail. (B) location of all identified transposon insertions. The insertion sites are
represented as bars with the residue after which the insertion occurred indicated by arrows at the top or bottom. (C) location of possible hotspots for transposition
(bars). The number of independent clones with insertions at that particular location is show in parentheses. The gray shaded area represents the putative receptor-
binding region where no transposon insertions were recovered. (D) Distribution of transposon insertions resulting in a lethal phenotype; (E) large plaque phenotype
(wild-type); (F) medium plaque phenotype; and (G) small plaque phenotype.
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plaque phenotype (SP) are 2–2.5 mm in diameter, all relative to
the size of wild-type plaques. Table 2 lists all the transposoninsertion mutants characterized and their plaque phenotypes.
The results indicate that a majority of the insertions is viable,
and some even exhibit wild-type levels of growth. Of the 57
Table 2
Library of transposon insertions in SINV E2
Construct a Location of insertion ORFb Plaque phenotype c CP production d E2 productiond Geometric mean e
E2-4:1 4 1 MP ++++ +++ 19
E2-4:2 4 2 SP ++++ + 5
E2-5 5 3 MP ++++ ++++ 35
E2-7 7 3 × ++++ +++ 8
E2-23 23 3 MP ++++ +++ 14
E2-28:1 28 2 LP ++++ ++++ 39
E2-28:2 28 2 LP ++++ ++++ 40
E2-29 29 3 LP ++++ ++++ 32
E2-33 33 2 × +++ + 4
E2-35 35 3 × +++ − ND
E2-53 53 1 × +++ + 4
E2-86:1 86 2 SP +++ +++ 12
E2-86:2 86 3 × +++ +++ 7
E2-89 89 2 MP ++++ ++++ 37
E2-90 90 3 × ++++ ++++ 8
E2-103 103 3 × ++++ − 3
E2-105:1 105 3 MP ++++ +++ 35
E2-105:2 105 3 MP ++++ ++++ 38
E2-107 107 2 × ++++ +++ 4
E2-109:1 109 3 × ++++ +++ 6
E2-109:2 109 3 × ++++ +++ 8
E2-113 113 3 × ++++ ++++ 7
E2-119:1 119 2 SP ++++ ++++ 22
E2-119:2 119 3 SP ++++ ++++ 17
E2-153 153 1 LP ++++ ++++ 37
E2-161 161 3 MP ++++ ++++ 18
E2-202 f 202 2 SP ++++ ++++ 25
E2-221:1 221 3 MP ++++ ++++ 20
E2-221:2 221 3 MP ++++ ++++ 33
E2-228 228 2 MP ++++ +++ 12
E2-242 242 3 SP ++++ ++++ 15
E2-249 249 2 SP ++++ ++++ 24
E2-275:1 275 3 MP ++++ ++++ 37
E2-275:2 275 1 SP ++++ ++++ 18
E2-279 279 1 SP ++++ ++++ 11
E2-311 311 1 × +++ +++ 5
E2-324 324 3 × +++ − 3
E2-326:1 326 2 LP ++++ ++++ ND
E2-326:2 326 2 LP ++++ ++++ ND
E2-326:3 326 2 LP ++++ ++++ ND
E2-327:1 327 3 × ++++ ++++ 4
E2-327:2 327 3 × +++ +++ 5
E2-329:1 329 2 MP ++++ ++++ 13
E2-329:2 329 2 MP ++++ ++++ 15
E2-335 335 2 LP ++++ ++++ ND
E2-338:1 338 1 × ++++ ++++ 7
E2-338:2 338 1 × ++++ ++++ 7
E2-340 340 2 MP ++++ ++++ 20
E2-341 341 2 SP ++++ ++++ 33
E2-347 347 1 SP ++++ +++ 10
E2-356 356 3 MP ++++ ++++ 21
E2-357 357 2 × ++++ ++++ 8
E2-360 360 1 SP ++++ ++++ 39
E2-370:1 370 1 LP ++++ ++++ ND
E2-370:2 370 2 MP ++++ +++ 37
E2-380:1 380 1 MP ++++ +++ 10
E2-380:2 380 2 SP ++++ +++ 6
Toto64 (wild-type) – – LP ++++ ++++ 35
a The number after the dash (-) represents the location of the insertion. Multiple insertions at the same location were distinguished by a number following a colon (:).
b ORF=open reading frame. See Table 1 for sequence.
c LP=large plaque, MP=medium plaque, SP=small plaque and ×=lethal.
d ‘++++’=100% of wild-type protein expression; ‘+++’=75% of wild-type protein expression; ‘++’=50% of wild-type protein expression; and ‘+’=25% of wild-
type protein expression.
e The results are an average of three experiments.
f E2-202 was created by cloning the transposon insertion sequence into this position.
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Fig. 3. One-step growth curves of selected transposon mutants. The growth
kinetics of the transposon mutants was compared to wild-type SINV in BHK
cells. (A) Transposon mutants with large plaque phenotype. (B) Transposon
mutants with medium plaque phenotype. (C) Transposon mutants with small
plaque phenotype. Media was replaced every 30 min for the first 2 h, and then
every hour for 12 h post-infection. Supernatant was collected at 4, 6, 8, 10 and
12 h post-infection and released virus was assayed by titration on BHK cells at
37 °C. The results represent the average of two experiments.
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These 18 insertions represent 15 unique sites in E2 (Fig. 2D).
The insertions that result in a lethal phenotype are primarily
clustered towards the N-terminus and the C-terminus of E2. The
lethal insertions are found between residues 33–113 at the N-
terminus and residues 311–357 at the C-terminus.
Of the 40 independent clones that gave rise to viable virus, 9
(6 unique sites) had wild-type-like plaque phenotypes, 17 (14
unique sites) had medium-plaque phenotypes and 12 (11 unique
sites) had small-plaque phenotypes (Figs. 2E, F and G). There
were several cases where two independent insertions at the same
location resulted in different phenotypes. In all cases this could
be attributed to different reading frames being used. For example
an insertion at amino acid 4 resulted in a MP phenotype when
ORF1 (Table 1) was expressed but a SP phenotype when ORF2
was expressed (Table 2 and Figs. 2F andG). ORF2 encodes three
cysteine residues whichmay disrupt the pattern of disulfide bond
formation within E2. This result indicates that the individual
amino acids that are been expressed have an impact on how well
the insertion is tolerated at a given location. Nineteen percent
(19%) of the inserts expressed ORF1, 37% expressed ORF2 and
44% expressed ORF3. Therefore, there was a slight preference
for ORF3 and ORF2 compared to ORF1. A tally of the
phenotypes exhibited by each ORF showed that 64% of mutants
expressing ORF1, 76% of mutants expressing ORF2 and 57% of
mutants expressing ORF3, were viable. These results indicate
that, although the expression of different ORFs at the same
location can result in different phenotypes, no ORF was
dramatically more disruptive than any other.
The plaque phenotype and growth properties of the
transposon mutants were further verified by one-step growth
analysis. Fig. 3 represents the one-step growth curves of a
representative cross-section of the transposon insertion library.
All the transposon mutants with a large-plaque phenotype had
similar growth kinetics to wild-type SINV (Fig. 3A). Fig. 3B
shows that a majority of the mutants with a medium-plaque
phenotype exhibited growth kinetics approximately two logs
lower than that of wild-type SINV. However, E2-105 and E2-
221 grew to titers only one log lower than the parental virus. All
the transposon mutants with a small-plaque phenotype had final
titers at least three logs lower than the parental virus (Fig. 3C).
Thus, plaque phenotypes correlated well with the replication
properties measured in single-cycle growth curves.
Insertions in E2 that result in reduced E2 transport to the
plasma membrane
The amount of E2 at the cell surface was quantified using
FACS analysis, in order to determine if any of the insertions
affected E2 transport to the plasma membrane. For insertions
that resulted in viable virus, BHK cells were infected at an MOI
of 1, whereas, in the case of the insertions that were lethal,
∼10 μg of in vitro transcribed RNAwas electroporated into the
cells. Cells were harvested 12 h post-infection and stained with
an anti-E2 polyclonal antibody, followed by a fluorescein-
conjugated goat anti-rabbit secondary antibody prior to FACS
analysis. Fig. 4A shows that when BHK cells infected withwild-type SINV (unfilled curve) were stained with a polyclonal
E2 antibody there was a shift in the number of strongly
fluorescent cells compared to mock infected BHK cells (filled
curve). The geometric mean represents the mean value of the
fluorescent signal under the curve. Therefore, the fluorescent
signal of the cells can be quantified as the geometric mean (Fig.
Fig. 4. Surface expression of E2. BHK cells were infected with wild-type SINV
(A) or an E2 transposon insertion mutant (E2-53) (B) at a multiplicity of
infection of 1. Cells were harvested 12 h post-infection and stained with a
polyclonal α-E2 antibody and a fluorescein-conjugated secondary antibody.
Cells were analyzed using a FACSCalibure flow cytometer. The grey filled-in
curve represents the signal from uninfected BHK cells. The shift in the signal
upon virus infection is shown by the clear curve and represents the expression of
E2 at the cell surface. The number above the curve is the geometric mean for the
region of the curve delineated by the line and is a measure of the amount of E2 at
the plasma membrane. The results represent data from a single experiment.
However, the experiment has been repeated three times, with consistent results.
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E2 in the plasma membrane. BHK cells infected with a mutant
expressing less E2 at the cell surface would have a lower
geometric mean compared to wild-type SINV-infected BHK
cells (compare Figs. 4A and B).
Fig. 4B represents the E2 surface expression for an insertion
mutant at E2-53 which exhibits low levels of E2 protein pro-duction (Table 2). This shows that when the level of E2
synthesis is low (less than 25% of wild-type in this case) or
undetectable, the cells exhibit a level of fluorescent signal
comparable to uninfected BHK cells. Therefore, there is no
detectable E2 in the plasma membrane for the insertions at E2-
33, E2-53 and E2-103 due to reduced levels of E2 expression.
However, there are several mutations that have wild-type levels
of E2 expression in the cytoplasm, but low levels of E2 at the
cell surface. There are 4 insertions within residues 107–113
(E2-107, E2-109:1, E2-109:2 and E2-113) that express wild-
type levels of E2, but have 3- to 6-fold lower E2 signal in the
plasma membrane and exhibit a lethal phenotype (Table 2).
Furthermore, two insertions at residue 119 (E2-119:1 and E2-
119:2) resulted in small-plaque phenotypes (Table 2). These
mutations also exhibited wild-type levels of E2 expression but
had a 2-fold reduction of the E2 signal at the cell surface.
Therefore, although sufficient levels of E2 are being expressed,
it is not making it to the plasma membrane, suggesting that
insertions in this region are disrupting E2 transport.
Several insertions towards the C-terminus of E2 (311–380)
also dramatically reduced levels of E2 protein at the plasma
membrane (Table 2). An insertion in the membrane-spanning
region at 380 resulted in a 4- to 8-fold reduction in the E2 signal
at the cell surface. Insertions in this region may destabilize the
protein in the membrane and therefore, affect protein transport
to the plasma membrane. An insertion at residue 370 (also in the
transmembrane), however, did not have a detrimental effect on
E2 transport as E2 expression at the cell surface was similar to
wild-type.
A transposon-insertion at E2-360 results in wild-type levels
of E2 at the plasma membrane, yet it has a small-plaque
phenotype (Table 2). Insertions at E2-340, E2-341 and E2-356
also resulted in medium-plaque or small-plaque phenotypes, but
had wild-type levels of E2 at the cell surface. Therefore,
insertions in this region do not affect protein expression or
transport but have defects in other aspects of the life cycle.
Effect of transposon insertions on the efficacy of neutralizing
monoclonal antibodies that map to E2
Most of the MAbs that neutralize SINV have been mapped to
E2. Insertions in E2 may alter the conformation of these surface-
exposed sites such that these neutralizing MAbs no longer bind
E2. By correlating the site of the insertion with the neutralizing
MAb inhibited by the mutation, the putative MAb binding site
can be mapped on E2. Virus neutralization assays were
performed with two SINV neutralizing MAbs (202 and 209)
that bind to different antigenic sites on E2 (Davis et al., 1987;
Meyer and Johnston, 1993; Strauss et al., 1991). Neutralizing
MAb 202 binds to the E2ab antigenic site of E2, which
comprises amino acid residues 181–216, whereas neutralizing
MAb 209 binds to the E2c antigenic site (Ubol andGriffin, 1991;
Wang et al., 1991). Escape mutants to E2c have been mapped to
residues 62, 96 and 159 (Pence et al., 1990). MAb 202 and 209
each neutralize wild-type SINVeffectively as shown in Fig. 5A
andB. However, an insertion at residue 119 resulted in decreased
efficacy of neutralization by each antibody (Figs. 5A and B). In
Table 3
Neutralization of E2 insertion mutants by MAb 202 and MAb 209
Virus Plaque
phenotype a
% Neutralization b
MAb 202 MAb 209
E2-4:1 MP 9% 7%
E2-23 MP ND 1%
E2-119:1 SP 17% 43%
E2-161 MP 96% 35%
E2-202 SP 5% 45%
E2-347 SP 94% 88%
E2-380:1 MP 2% 73%
Toto64 (wild-type) LP 95% 92%
a LP=large plaque; MP=medium plaque; SP=small plaque.
b See Materials and methods for experimental details.
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are fully or partially resistant to neutralization, indicating that
some of these mutants may have impaired ability to bind cellular
receptors. Insertions at E2-4, E2-119, E2-202 and E2-380 of E2
were able to prevent neutralization by MAb 202, whereas
insertions at residues E2-4, E2-23, E2-119, E2-161 and E2-202
were able to prevent neutralization by MAb 209. Some of these
insertion sites may represent residues to which the MAbs bind
directly, whereas some represent sites that merely alter the
conformation of the protein such that the MAbs can no longer
bind. In either case, this information would be useful in planning
a strategy to ablate the natural tropism of SINV.
Insertions in E2 that may produce noninfectious particles
An ELISA was used in order to determine if any of the
insertion mutants with a lethal phenotype produced noninfec-
tious virions. Ten-fold concentrated culture supernatant from
BHK cells electroporated with the mutant constructs was
assayed for the presence of virions using a polyclonal antibody
against E2. Table 4 presents the ELISA data in terms of the
optical density (OD at 450 nm) for each of the constructs tested
as well as in terms of a percentage of the wild-type (Toto64)
signal. The results indicate that a lethal insertion at E2-7 has an
OD450 value of 0.427 which is 86% of the wild-type signal. This
strongly suggests that this mutation may be producingFig. 5. Neutralization of E2 transposon insertion mutations by MAb 202 and
MAb 209. 100 pfu of Toto64 or of E2-119 were each incubated with different
concentrations of MAb 202 (A) or MAb 209 (B) for 30 min. The titer of the
resulting virus was determined by standard plaque assay on BHK cells at 37 °C.
The results are the average of three experiments. The error bars indicate the
standard deviation.noninfectious particles. BHK cells electroporated with the
RNA genome of this construct were analyzed by transmission
electron microscopy (TEM) 12 h post-electroporation. The
TEM images demonstrated the presence of budding virions at
the surface of BHK cells electroporated with the E2-7 construct
(data not shown). In order to confirm that noninfectious virions
were produced, an attempt was made to isolate these particles.
BHK cells were electroporated with the in vitro transcribed
RNA of the mutant construct and then a virion fraction was
purified from the media using standard techniques. We were
unable to visualize any virus particles by negative-stain EM
despite the observations from the TEM. Thus, the virions may
not have survived the harsh purification steps, or the number of
virions may be below the detection limit for negative-stain EM
analysis. The other lethal insertions tested had OD450 values
closer to mock levels. E2-33 resulted in 48% of the wild-type
E2 signal. However, immunoblot analysis has revealed that E2-
33 has low levels of E2 expression (Table 2), and this disruption
of E2 expression may explain the lethal nature of the insertion.
Discussion
Transposon linker-insertion mutagenesis as a method to
produce an insertion library
In the past decade much effort has focused on the develop-
ment of alphaviruses as vectors for gene expression and asTable 4
ELISA to detect production of non-infectious particles
Virus OD450
a % of wild-type signal Plaque phenotype b
E2-7 0.427 (0.02) 86% ×
E2-33 0.241 (0.02) 48% ×
E2-86:2 0.119 (0.01) 24% ×
E2-90 0.165 (0.02) 33% ×
E2-119:1 0.481 (0.02) 97% SP
E2-311 0.125 (0.03) 25% ×
E2-338:1 0.248 (0.01) 50% ×
Toto64 (wild-type) 0.498 (0.05) 100% LP
Mock 0.121 (0.01) 24% –
a The results represent the average of three experiments. The standard
deviation is presented in parentheses.
b LP=large plaque; SP=small plaque; ×= lethal.
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Schlesinger and Dubensky, 1999; Xiong et al., 1989). The virus
has been structurally characterized, having T=4 icosahedral
symmetry, and the atomic structures of the capsid (amino acids
106–264) and E1 (ectodomain) proteins have been determined
(Choi et al., 1991; Lee et al., 1996; Lescar et al., 2001; Zhang et
al., 2002). However, the structure of the receptor-binding
protein, E2, has been elusive. Attempts to express and crystallize
have so far failed to produce diffracting crystals of E2
(unpublished data, R.J. Kuhn and M.G. Rossmann). Knowledge
of the different functional domains of E2 would be invaluable in
the design of a targeted alphavirus gene therapy vector. In order
to functionally characterize the different regions of E2 in the
absence of a three-dimensional structure, an E2 insertion library
was generated. A previous random linker insertion mutagenesis
study, where the 15 amino acid Rift Valley fever virus (RVFV)
4D4 epitope was inserted into E2, demonstrated that it was
possible to incorporate heterologous peptides into E2 (London et
al., 1992). That study lead to the characterization of two
insertions sites (at E2-3 and E2-244) that were able to
accommodate the RVFV 4D4 epitope. Our study extends this
work by creating a transposon-based linker insertion library in
E2 and characterizing both permissive and non-permissive sites
for the insertion of the 19-residue transposon insertion.
A transposon-based mutagenesis strategy was adopted,
because it afforded a rapid way of randomly inserting a linker
into E2 and generating many independent clones. The EZ∷TN
In Frame Linker Insertion Kit was chosen because the inserted
linker is open in all three reading frames, thereby ensuring that
all insertions are productive. From an initial pool of 200 KanR/
CamR colonies, we were able to identify 56 that had insertions
specifically in the E2 region of the SINV cDNA. The calculated
percentage of insertions in the E2 sequence is 28%, which is
close to the theoretical value of 34%, based on a completely
random distribution of insertions. Although the mutagenesis
system is in theory random, there are 15 locations represented
two or more times among the 56 independent clones; thus, 27%
of the transposon insertions are repeats. The maximum number
of times a particular location was represented in the library was
three (E-326) (Table 2). Therefore, the transposon insertions are
not random, and as a result there are some regions with a high
incidence of insertions and some with no insertions. This is
exemplified by the 170–220 region of E2. Assuming a
completely random distribution of transposon insertions, the
probability that there will not be an insertion in the 170–220
region among the 400 colonies screened, is very low (∼10−16).
It has previously been reported that Tn5-based transposases
have a low efficiency of transposition into GC-rich sequences
(Herron et al., 2004). An analysis of the 170–220 region reveals
that it has a high GC content compared to the average GC
content of E2, while an analysis of the nucleotide composition
in regions with a high incidence of insertions (such as the region
from 103 to 113) reveals that they are relatively AT-rich. Thus,
this may explain the lack of transposon insertions in this region.
Two independent insertions at the same residue may express
different ORFs and thus, exhibit different phenotypes based on
the nature of the sequence. Two independent insertions at E2-86(E2-86:1 and E2-86:2) had the most dramatic impact. E2-86:1
expressed ORF2 and gave rise to a viable mutant (SP) and E2-
86:2 expressed ORF3 which resulted in a lethal phenotype
(Table 2). This indicates that insertion mutations, although they
may indicate regions which can or cannot tolerate insertions, are
not necessarily a good indicator of how well a heterologous
sequence will be tolerated at the same location.
Functional characterization of E2 based on transposon
linker-insertion mutagenesis
The ability of E2 to readily tolerate insertions in spite of its
multiple roles in the SINV life cycle is quite remarkable. These
roles include its requirement along with E1 to drive virus
assembly and budding, its role in receptor binding, and the
conformational changes necessary in the fusion process.
Despite these important functional roles, E2 is the least
conserved of the alphavirus structural proteins (Strauss and
Strauss, 1994). An analysis of E2 protein expression in the
transposon mutants by Western immunoblot revealed that only
three insertions completely abolished E2 expression (insertions
at amino acids E2-35, E2-103 and E2-324). Other insertions
surrounding amino acid 35 (E2-33 and E2-53) also resulted in
dramatically reduced E2 expression (Table 2). This suggests
that the region encompassing amino acids 33–53 is important
for proper protein folding and stability. The fact that different
ORFs resulted in the same phenotype indicates that it is the
insertions in general that are destabilizing the protein and not
any one sequence in particular. An analysis of the secondary
structure prediction for E2 suggests that this region comprises a
helix, loop and an extended β-sheet structure (data not shown)
(PredictProtein, Rost et al., 2003).
Lethal insertions were located between residues 33–113 at
the N-terminus and 311–357 close to the membrane-spanning
region of E2. Some of the lethal phenotypes can be explained by
protein folding problems as explained above. However, a group
of 4 insertions between residues 107 and 119 had close to wild-
type levels of E2 expression, but had a lethal phenotype. FACS
analysis revealed that there was very little E2 at the cell surface.
The E2 signal for these mutants was 3- to 6-fold reduced
compared to that of wild-type (Table 2). Thus, insertions in the
107–119 region impair proper E2 transport to the plasma
membrane. However, an insertion at E2-105 exhibited wild-
type levels of E2 at the cell surface, while an insertion at 103
abolished E2 protein expression. A previous linker insertion
mutagenesis study using the RVFV 4D4 epitope (London et al.,
1992) identified an insertion at residue 88 that was lethal. In that
study, the authors were unable to detect any protein synthesis.
We have recovered an insertion at E2-90 that has wild-type
levels of protein expression, but impaired transport.
The insertions that produced viable mutants were distributed
throughout the E2 glycoprotein, with a high density being found
between residues 1–30 and 329–381. The replication pheno-
types of the transposon mutants were independently verified by
plaque size and one-step growth analyses (Fig. 3). The growth
kinetics and plaque phenotypes were found to be consistent for
a representative cross section of the transposon insertion library
143C.K. Navaratnarajah, R.J. Kuhn / Virology 363 (2007) 134–147(see Figs. 3A–C). Three of the insertions that gave rise to
viruses with large-plaque phenotypes were located towards the
N-terminal half of E2, at amino acid positions 28, 29 and 153.
E2-28 and E2-29 are located at the beginning of a predicted
helix, whereas E2-153 is located in a predicted random coil
(data not shown). These insertions are of interest, because they
identify potential sites for the insertion of targeting ligands. The
insertions at positions 28 and 29 are most probably surface-
accessible based on the location of the N-terminus of E2 and
residue 45 (Mukhopadhyay et al., 2006; Paredes et al., 1998).
Based on the position of residue 160 as previously reported, the
insertion at 153 would also be surface-accessible (Mukhopad-
hyay et al., 2006). Western blot analysis and FACS analysis
have shown that these mutants exhibit wild-type levels of E2
expression and transport to the cell surface (Table 2). One-step
growth analysis reveals that the growth kinetics of these
transposon insertion mutants are similar to wild-type SINV
(Fig. 3A).
The other three mutants with large-plaque phenotypes are
located at residues 326, 338 and 370 and, therefore, unlikely to
be surface-accessible. The site at 370 is in the middle of the
transmembrane region of the glycoprotein. In order for the 26
amino acid TM region to tolerate a 19 amino acid insertion,
the E2 protein needs to shift the extra amino acids to either
side of the membrane. Due to space constraints within the
virion, and the need for the cytoplasmic domain of E2 to
interact with the capsid protein, it is more likely that the bulk
of these extra amino acids would end up on the ectodomain of
the virus (Hernandez et al., 2005). In fact, the predicted loca-
tion of the transmembrane helix by several secondary structure
prediction algorithms supports this conclusion (data not shown)
(PredictProtein, Rost et al., 2003).
The insertion at residue 202 is in a highly antigenic region of
E2. Many escape mutants to neutralizing MAbs of alphaviruses
have mapped to the amino acid residues between 170 and 220,
implicating them in receptor binding (Davis et al., 1987; Meyer
and Johnston, 1993; Smith et al., 1995; Strauss et al., 1991).
Therefore, the small-plaque phenotype of the mutant at 202 may
be explained by disruptions in receptor binding as a result of the
insertion. To determine if any of the insertions may have
affected cell receptor binding, we assayed the ability of SINV
neutralizing MAbs to neutralize the insertion mutants. We chose
mutants that had medium or small-plaque phenotypes and
expressed wild-type levels of E2. The neutralization assays
show that some of the insertions did prevent virus neutralization
by MAb 202 and 209 (Fig. 5 and Table 3). The insertions that
were able to escape or partially escape the neutralizing effects of
the MAbs may also have impaired ability to interact with
cellular receptors and this may partly explain their medium- or
small-plaque phenotypes. These insertions could be of great
value in the design of a SINV gene therapy vector. Insertions
into this region may simultaneously allow directed targeting of
the virus as well as partial ablation of native receptor-binding
ability. Previously Dubuisson and Rice (1993) demonstrated
that a small insertion (15 amino acids) between E2 amino acids
69 and 74 dramatically reduced receptor binding. However,
insertion of large targeting ligands at this location adverselyaffected virus assembly and resulted in a reduction in viral titers
(Ohno et al., 1997; Sawai and Meruelo, 1998). The insertions
mentioned above represent alternate sites for the incorporation
of targeting ligands into E2.
Several insertion mutants exhibited close to wild-type levels
of E2 protein expression and sufficient transport to the plasma
membrane, yet had lethal phenotypes. The levels of E2 transport
to the cell membrane in these mutants were higher than some of
the viable mutants. This suggests that lower levels of E2 may
not be the only reason for the lethal phenotype of these mutants.
Such mutants may have problems with assembly, fusion or
receptor binding. If the mutants had problems with fusion or
receptor binding, but not assembly, then one would expect to
see the production of noninfectious virions. An ELISA-based
detection system was used to determine if any of the mutants
with lethal phenotypes were producing noninfectious particles.
The results indicate that E2-7 could be producing noninfectious
particles. However, attempts to purify the noninfectious virions
were not successful (data not shown).
The linker insertion mutagenesis study by London et al.
(1992) recovered 10 insertions near the N-terminus of E2 and
16 insertions near residue 240. The researchers determined that
a majority of the insertions near the N-terminus produced the E2
glycoprotein and they further demonstrated that an insertion at
E2-3 was viable and in fact exhibited wild-type-like growth
properties. This is consistent with our results, where the N-
terminus was shown to tolerate 19 amino acid insertions (Fig.
2). London and colleagues also determined that an insertion at
E2-244 was viable. Our results show that insertions at E2-242
and E2-249 are also viable in agreement with these previous
results.
Fig. 6 summarizes the functional regions of E2 based on the
characterization of the transposon linker-insertion library. The
N-terminus of E2 (amino acids 1–30) is amenable to insertion of
the transposon and is involved in receptor binding. Residues 33–
53 comprise an important secondary structural element as
transposon insertions in this region eliminate E2 protein
production. Amino acid residues 86–119 are also important
for protein stability as insertions in this region are lethal, and
moreover, this region is predicted to be part of an ordered
structure (FoldIndex, Prilusky et al., 2005; data not shown). This
conclusion is further supported by the results of London et al.
(1992) that demonstrated that an insertion near residue 88 was
defective in protein production. Insertions at certain residues
within 86–119 (amino acids 86, 90 and 107–113) have greatly
reduced protein expression at the plasma membrane, suggesting
a possible role in protein transport for this region. However,
since this region lies within the lumen of the ER it is unlikely to
directly interact with the transport machinery of the cell.
Therefore it is likely that insertions in this region are impacting
protein folding, thus triggering the ER quality control machinery
to block the transport of the glycoprotein to the plasma
membrane. The region between amino acids 120 and 161 is
amenable to insertion of the transposon and is also implicated in
receptor binding. The transposon insertion at E2-202 impaired
receptor binding, which is consistent with its role as the receptor
binding region of E2. Finally, insertions adjacent to and within
Fig. 6. Functional regions of SINV E2. The functional regions of E2 based on the characterization of the E2 transposon linker-insertion library have been mapped onto
a schematic of SINV E2. The color scheme represents the plaque phenotype of the insertion mutants. Blue represents a wild-type-like phenotype (large plaque), green
represents a medium plaque phenotype, brown represents a small plaque phenotype and red indicates that the insertions were lethal.
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the plasma membrane. Insertions in this region may disrupt E1–
E2 and E2–E2 interactions thus affecting transport. Insertions in
the membrane-spanning region may destabilize the protein
within the membrane, thereby disrupting transport.
The E2 transposon insertion library, in addition to revealing
the function of different regions of E2, has also helped identify
several regions within the protein which can tolerate insertions
without adverse effects on virus growth. Some of these sites
(E2-28, E2-29 and E2-153) are predicted to be surface-
accessible and represent potential sites for the insertion of
targeting ligands. The ability to insert a targeting ligand without
perturbing virus growth is significant as it will allow the
generation of the high titers that are required for gene-therapy
applications.
Materials and methods
Viruses and cells
All viruses were grown at 37 °C in BHK-15 cells propagated
in Eagle's minimal essential medium (MEM) (Invitrogen)
supplemented with 7.5% fetal bovine serum (FBS), unless
otherwise noted. All E2 transposon insertion mutations were
constructed from pToto64, a full-length cDNA clone of SINV
that has been previously described (Owen and Kuhn, 1996). All
cells were grown at 37 °C in the presence of 5% CO2.
Random transposon linker-insertion mutagenesis
A fragment of the SINV cDNA clone, pToto64 (the BstEII–
BssHII fragment, nt 7472–9804), encoding the capsid protein,
E3 and the first 407 amino acids of E2, was subcloned into
pJRtac99 (CamR) (American Type Culture Collection) to
generate pJRtac99-E2 (Fig. 1). This plasmid was then used in
an in vitro transposon linker-insertion reaction according to themanufacturer's instructions (EZ∷TN In-Frame Linker Insertion
Kit, Epicentre Technologies, Madison, WI). This resulted in the
insertion of the ∼1100 base pair (bp) EZ∷TN <NotI/Kan-3>
transposon randomly into the plasmid to generate pJRtac99-E2/
TnKan. Plasmids containing the transposon were selected by
plating on media containing both kanamycin (50 μg/ml) and
chloramphenicol (25 μg/ml). The resulting colonies were
individually grown in 3 ml of LB medium supplemented with
both chloramphenicol (50 μg/ml) and kanamycin (25 μg/ml).
pJRtac99-E2/TnKan DNA was extracted from these cultures
with the Qiaprep Spin Miniprep Kit (Qiagen) according to the
manufacturer's instructions. In order to identify and isolate
transposition events that occurred within the SINV cDNA
sequence, the resulting plasmids were digested with BstEII and
BssHII. Restriction-digested DNA was analyzed by gel
electrophoresis, and the BstEII–BssHII fragments containing
transposon inserts were identified by their increase in size by
1100 bp. Fragments with transposon inserts were gel purified
using the GFX Kit (Amersham Biosciences) for DNA
purification according to the manufacturer's instructions. The
BstEII–BssHII fragments were then cloned into the SINV
cDNA by ligation with a BstEII–BssHII digested pToto64
plasmid to generate pToto64–TnKan. The pToto64–TnKan
plasmids were further restriction digested with NotI in order to
eliminate the KanR gene and the resulting plasmid self-ligated
to regenerate the full-length SINV cDNA, pToto64Tn, now
containing a 19-amino acid insertion in the E2 coding sequence.
The resulting pToto64Tn plasmids were sequenced with
primers flanking the E2 coding sequence to determine the
location of the transposon inserts.
High-throughput screen to identify insertions between E2
residues 170 and 220
KanR/CamR colonies were picked using the QPix2 (Genetix)
automated colony picker and placed in 200 μl of LB broth
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plates were generated in this manner and incubated at 37 °C for
5 h. 5 μl of this culture was used to set up colony PCR reactions
in a total volume of 25 μl in 96-well plates. The primers used
specifically amplified the sequence between E2 residues 160–
230. If there was a transposon insertion within this region the
size of the PCR product would have been ∼1300 bp vs.
∼200 bp if there was no insertion. The PCR products were
analyzed on 96-well precast 1% agarose gels (E-Gels 96,
Invitrogen). The BioMek Fx (Beckman Coulter) was used to
transfer the PCR products to the gels. In all, 3×96-well plate
PCR reactions were screened.
Construction of an insertion at E2 residue 202
Since we were unable to isolate any insertions in the 170–
220 region, the 15 amino acids of the transposon insertion
sequence was inserted at E2 residue 202 by an overlap PCR
technique. The insertion was created in pJRtac99-E2 using a
complimentary pair of mutagenic oligonucleotide primers and
two outside primers to generate pJRtac99-E2/202Tn. This
plasmid was digested with BstEII and BssHII and the SINV
cDNA fragment was inserted into a similarly digested pToto64
vector to generate pToto64–Tn202.
In vitro transcription and transfection of E2 transposon
mutants and rescue of mutant viruses
Following sequencing to determine the location of the
transposon insertions, the full-length SINV-derived cDNA
clones were linearized with SacI and in vitro transcribed with
SP6 RNA polymerase (Amersham Biosciences, Piscataway,
NJ). For electroporation of BHK-15 cells, subconfluent mono-
layers of cells grown in T-75 culture flasks (∼1.5×107 cells)
were harvested by trypsinization and washed twice with
phosphate-buffered saline (PBS) before final suspension in
400 μl of PBS. The resulting cells were combined with the in
vitro transcribed RNA, placed in a 2-mm gap cuvette (BioRad,
Hercules, CA), and electroporated (two pulses at settings of
1.5 kV, 25 μF and 200Ω) using a GenePulser II electroporation
apparatus (BioRad). Following a 5-min recovery at room
temperature, cells were suspended in MEM supplemented with
10% FBS. The media was harvested 48 h post-electroporation
and assayed for the presence of infectious virus using a standard
plaque assay. Viable E2 transposon insertions were plaque-
purified to generate viral stocks. Plaque phenotypes were
determined 48 h post-infection by comparing Toto64-Tn
plaques to wild-type Toto64 plaques.
Western blot analysis
The expression of E2 in lysates of BHK-15 cells electro-
porated with Toto64-Tn RNA was analyzed by Western
immunoblots using a polyclonal anti-E2 antibody specific for
the cytoplasmic domain of E2 (a generous gift of M. Schle-
singer). The expression of the capsid protein was also analyzed
as an internal control with a polyclonal anti-capsid proteinantibody. BHK-15 cells were harvested 24 h post-electropora-
tion and cytoplasmic extracts generated. Samples were run under
denaturing conditions in 13%Bis–Tris acrylamide gels.Western
immunoblots were performed using the ECL Western Blot
Detection System (Amersham Biosciences).
Immunofluorescence assay
Immunofluorescence assay (IFA) was performed on BHK
cells grown on glass coverslips. Cells were washed with PBS
and subsequently treated with methanol for 15 min at room
temperature. Following fixation, cells were washed with PBS
followed by a 5-min incubation in PBS with 10 mg/ml BSA.
Methanol-treated cells were then subjected to adsorption with
primary antibody (anti-E2 or anti-capsid protein) for 45 min at
37 °C. Following primary antibody incubation, cells were
washed with PBS and subsequently incubated for 45 min at
37 °C with a fluorescein-conjugated goat anti-rabbit antibody in
PBS (10 mg/ml BSA). Following secondary antibody adsorp-
tion, cells were washed with PBS and finally with distilled water.
Coverslips were then placed on microscope slides, cell side
down, in the presence of Fluorosave reagent (Gibco). Fluor-
escent images were visualized using an inverted epi-fluorescent
microscope equipped with a digital CCD camera.
One-step growth analysis
BHK cells were infected with the indicated virus at a
multiplicity of infection of 1. Media over the cells was re-
placed every 30 min for the first 2 h and then every hour for
12 h post-infection. Supernatant was collected at the indicated
times and assayed for released virus by titration on BHK cell
monolayers.
Flow cytometry
For E2 transposon-insertion mutants that formed viable
virus, BHK-15 cells (∼2×106) were infected at a multiplicity of
infection of 1. The cells were harvested 12 h post-infection by
treating with trypsin–EDTA for 30 s and then suspending the
cells gently in MEM supplemented with 10% FBS. The cells
were transferred to an Eppendorf tube and washed twice with
PBS supplemented with 1% FBS. The cells were incubated on
ice for 1 h with a 1:100 dilution of a polyclonal antibody against
the ectodomain of E2 (a generous gift from J.H. Strauss). The
cells were washed three times with PBS (1% FBS) and then
incubated on ice in the dark for 30 min with a fluorescein-
conjugated goat anti-rabbit secondary antibody. The cells were
washed three times with PBS (1% FBS) and suspended in
500 μl of PBS. The cells were analyzed using a FACSCalibure
flow cytometer (BD Biosciences, CA). Control staining was
performed with uninfected cells or by omitting the primary anti-
E2 antibody. Results are expressed as a plot of frequency versus
log fluorescence or the geometric mean. For insertion mutants
of E2 that were lethal, ∼10 μg of in vitro transcribed RNAwere
electroporated into BHK-15 cells as described previously. Cells
were harvested and stained as described above.
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To examine the effect of transposon linker insertions in E2
on the ability of E2 neutralizing antibodies to neutralize SINV
infections, 100 plaque-forming units (pfu) of the E2 insertion
mutants were incubated with 10-fold dilutions of the neutraliz-
ing antibody and rabbit complement for 1 h. The different
virus–antibody complexes were adsorbed to cells for 1 h at
room temperature and then overlaid with 1% agarose in 1×
MEM, supplemented with 1% FBS. Plaques were stained (4%
Neutral Red in PBS) and counted 48 h post-infection.
Transmission electron microscopy
BHK-15 cells were electroporated with Toto64-Tn or Toto64
in vitro transcribed RNA as described previously. The cells were
fixed (in 2% glutaraldehyde and reduced osmium) 12 h post-
electroporation and then embedded in 1.5% agarose. The
samples were diced and dehydrated for transmission electron
microscopy.
ELISA
BHK-15 cells were electroporated with Toto64-Tn or Toto64
in vitro transcribed RNA as described previously. The media
was harvested 24 h post-electroporation and concentrated with a
100,000 MWCO concentrator (Microcon). The concentrated
media (50 μl) was applied to a 96-well Polysorp ELISA plate
overnight at 4 °C. The samples were blocked with 5% BSA in
PBS for 2 h followed by three washes with PBS (0.1% Tween
20). A 1:100 dilution of a polyclonal anti-E2 antibody was
applied to the sample for 1.5 h, followed by three washes with
PBS (0.1% Tween 20). A 1:1000 dilution of an HRP-conjugated
goat anti-rabbit secondary antibody was applied to the sample
for 1 h, followed by three PBS (0.1% Tween 20) washes. The
TMB Peroxidase Detection system was used to develop the
ELISA according to the manufacturer's instructions. The optical
density (OD) was determined at 450 nm. Uninfected cells were
used as a negative control and cells electroporated with Toto64
in vitro transcribed RNA were used as a positive control.
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